Clinical Trial Update: Adjuvant Valproate for High Grade Sarcomas [Phase 1]

View source ↗

Summary

Phase 1 trial of adjuvant valproate for high-grade sarcoma has been terminated. Sponsor: Columbia University.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sarcoma

Drugs mentioned

• Valproate (valproate)

Snippet

Sponsor: Columbia University | Conditions: High Grade Sarcoma | Phase 1 | Status: TERMINATED